News and Comments

Onyx (ONXX) Was Right All Along

  Monday, July 26, 2010

In October 2009, Onyx (ONXX) paid $276 million up front to acquire the privately held Proteolix to get to its multiple myeloma drug carfilzomib. It promised $535 million in future payments largely contingent on carfilzomib's approval. As usual, investors did not like Onyx paying money, because investors do not like any company to pay money to develop or acquire state-of-the- art products. When somebody hates something he sees everything in it with pessimism. Onyx put its hands on carfilzomib, which looked very promising for multiple myeloma cases resistant to current treatments. The breakthrough multiple myeloma drugs Velcade (bortezomib) and Revlimid (lenolidamide) could not prevent the cancer from recurring and failed to work at all on a large percentage of recurrent cancer.  More...


Recent Postings


Archive


Tags

PORTOLA (PTLA) Telaprevir Advaxis (ADXS) AERIE PHARMACEUTICALS Vitae Pharmaceuticals (VTAE) RenenxBio (RGNX) Tysabri GlaxoSmithKline (GSK) Sanofi-Aventis (SAN) ZALTRAP™ Editas (EDIT) Pluristem (PSTI) ImmunoGen (IMGN) Biocryst (BCRX) PTC Therapeutics (PTCT) SYNTA (SNTA) Ocular Therapeutix (OCUL) Intermune (ITMN) Human Genome Sciences (HGSI) Zerenex Merck (MRK) Theravance (THRX) Idenix (IDIX) VANDA (VNDA) Multiple Myeloma Galena (GALE) GUARDIAN HEALTH Velcade (bortezomib) Ridaforolimus Seattle Genetics (SGEN) Ariad (ARIA) CEMPRA (CEMP) OSI (OSIP) Global Cell Therapeutics (GBT) Illumina (ILMN) Anacor (ANAC) Elan (ELN) Bellicum (BLCM) Onyx (ONXX) SUNESIS PHARMACEUTICALS (SNSS) Intrexon (XON) IDERA (IDRA) Endometrial Cancer Jazz Pharmaceuticals (JAZZ) ADVENTRIX (ANX) ISIS (ISIS) JUNO (JUNO) Prosensa (RNA) Biogen Idec (BIIB) Regeneron (REGN) Aimmune Therapeutics (AIMT) HALOZYME (HALO) Roche (RHHBY) ARGOS (ARGS) Prolor Biotech (PBTH) KERYX (KERX) Genentech Sarepta (SRPT) Sangamo (SGMO) Dynavax (DVAX) MODERNA Mirati Therapeutics (MRTX) Cytokinetics (CYTK) KITE (KITE) Alnylam (ALNY) Sanofi (SNY) Xoma (XOMA) Herceptin Exelixis (EXEL) Agenus (AGEN C4 Therapeutics CRISPR Therapeutics (CRSP) ABBVIE (ABBV) REGULUS (RGLS) Micromet (MITI) Agenus (AGEN) NANTKWEST (NK) Valeant Pharmaceuticals International (VRX) Anadys (ANDS) Intercept (ICPT) Abbott Laboratories (ABT) Alder Biopharmaceuticals (ALDR) TOKAI (TKAOI) Ziofpharm (ZIOP) Dendreon (DNDN) AstraZeneca (AZN) SERES THERAPEUTICS (MCRB) Sequenom (SQNM) Rapamune CompuGen (CGEN) galapagos (GLPG) Auspex (ASPX) ARCA (ABIO) Human Longevity (HLI) Bristol-Myers Squibb (BMY) ACADIA (ACAD) Incyte (INCY) Roche (ROCHE) AGOS (ARGS) Vertex (VRTX) NEKTAR (NKTR)) Sanofi (SNA) Adaptimmune (ADAP) Trastuzumab-DM1 Theravance Bio Pharma (TBPH) Spike Therapeutics (ONCE) Inovio (INO) Amgen (AMGN) BIOMARIN (BMRN) Revlimid (lenolidamide) Array Pharmaceuticals (ARRY) NOVOCURE (NVCR) Benlysta (belimumab) Ionis (IONS) INNOVIVA (INVA) Gilead (GILD)